NASDAQ: BIOTInstinct Bio Technical Co Inc Stock
$0.20+0.01 (+5.26%)
Updated Oct 27, 2026
BIOT Price
$0.20
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$0.17
52 Week High
$50.00
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.41
Operating Cash Flow
N/A
Beta
3.77
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BIOT Overview
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BIOT's potential to beat the market
- BIOT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
BIOT
RankedUnranked of 22
RankedUnranked of 22
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $65.78 | A | |
| $29.20 | A | |
| $5.39 | B |
Be the first to know about important BIOT news, forecast changes, insider trades & much more!
BIOT News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BIOT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BIOT's short-term assets ($1.80M) exceed its short-term liabilities ($821.28k)
Short-term Liabilities Financials
BIOT's short-term assets ($1.80M) exceed its long-term liabilities ($44.05k)
Long-term Liabilities Financials
BIOT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
There are 30 more BIOT due diligence checks available for Premium users.
Valuation
BIOT's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
Assets to liabilities
Assets
$3.1M
Liabilities
$910.9k
Debt to equity
0.41
BIOT's short-term assets ($1.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BIOT's short-term assets ($1.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BIOT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
BIOT vs Household & Personal Product Stocks
Instinct Bio Technical Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.